Three genetic variations (ERCC2: rs238406, XRCC1: rs25487, NBN: rs2735383) had diverse frequency in CHB patients with liver cirrhosis and with no fibrosis, highlighting their possible role in HBV-induced liver disease progression. This evidence concerns the gene ERCC2 and fibrosis.